{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_aflibercept",
          "name": "Aflibercept"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_copanlisib",
          "name": "Copanlisib"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_belimumab",
          "name": "Belimumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sunitinib",
          "name": "Sunitinib"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.75,
          "safety_risk": 0.2,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.08
        },
        "graph_signals": {
          "support_weight": 1.7,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Eculizumab",
              "pro": [
                "d_a_hus"
              ],
              "con": [
                "n_adv_eculizumab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "已知 Eculizumab 通过 CD5 作用改善 atypical HUS"
          ],
          "safety_risk": [
            "Skeptic 指出可能导致不良表型"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "安全性与长期疗效影響未完全验证"
        ]
      },
      {
        "hypothesis_id": "H2",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.75,
          "safety_risk": 0.2,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.08
        },
        "graph_signals": {
          "support_weight": 1.7,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Ravulizumab",
              "pro": [
                "d_a_hus"
              ],
              "con": [
                "n_adv_ravulizumab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "已知 Ravulizumab 通过 CD5 作用改善 atypical HUS"
          ],
          "safety_risk": [
            "Skeptic 指出可能导致不良表型"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "安全性与长期疗效影響未完全验证"
        ]
      },
      {
        "hypothesis_id": "H3",
        "score": 0.56,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Aflibercept",
              "pro": [
                "pathway_inhibition"
              ],
              "con": [
                "n_adv_aflibercept"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "有文献支持其通过通路抑制影响疾病"
          ],
          "safety_risk": [
            "Skeptic 指出可能导致不良表型"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "机制连通性不足，疗效尚待验证"
        ]
      },
      {
        "hypothesis_id": "H4",
        "score": 0.65,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.65,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Corticosteroids",
              "pro": [
                "pathway_inhibition"
              ],
              "con": [
                "n_adv_corticosteroids"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "广泛认为可以通过免疫调节来改善病情"
          ],
          "safety_risk": [
            "Skeptic 指出可能导致不良表型"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "对长期疗效的影响缺乏足够的数据"
        ]
      },
      {
        "hypothesis_id": "H5",
        "score": 0.7,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.75,
          "safety_risk": 0.1,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "通过血液净化机制帮助改善病例"
          ],
          "safety_risk": [
            "无明显的安全性警告医学确认"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.5,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.2,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "推测作用于相关免疫通路"
          ],
          "safety_risk": [
            "Skeptic 指出可能导致不良表型"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "缺乏清晰表型改善证据"
        ]
      },
      {
        "hypothesis_id": "H7",
        "score": 0.45,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.08,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "有研究表明刻意将其用作免疫抑制药"
          ],
          "safety_risk": [
            "Skeptic 指出可能导致不良表型"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "缺乏直接相关的疗效证据"
        ]
      },
      {
        "hypothesis_id": "H8",
        "score": 0.5,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.5,
          "safety_risk": 0.2,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "推测作用于免疫调节"
          ],
          "safety_risk": [
            "Skeptic 指出可能导致不良表型"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "缺乏直接相关的疗效证据"
        ]
      },
      {
        "hypothesis_id": "H9",
        "score": 0.4,
        "components": {
          "mechanism_fit": 0.35,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.4,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "潜在影响相关的细胞通路"
          ],
          "safety_risk": [
            "Skeptic 指出可能导致不良表型"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "缺乏清晰的疗效证据"
        ]
      },
      {
        "hypothesis_id": "H10",
        "score": 0.58,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.55,
          "safety_risk": 0.15,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "文献中表明可影响相关免疫途径"
          ],
          "safety_risk": [
            "相对安全性较好"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "缺乏清晰的疗效证据"
        ]
      },
      {
        "hypothesis_id": "H11",
        "score": 0.38,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.2,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.4,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "有理论基础支持其可能的免疫调节作用"
          ],
          "safety_risk": [
            "Skeptic 指出可能导致不良表型"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "实证证据不足以支持其疗效"
        ]
      },
      {
        "hypothesis_id": "H12",
        "score": 0.45,
        "components": {
          "mechanism_fit": 0.35,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.2,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.4,
          "contradiction_weight": 1.55,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "推测可能影响相关的血管生成通路"
          ],
          "safety_risk": [
            "Skeptic 指出可能导致不良表型"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "缺乏直接证据支持其疗效"
        ]
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H5",
      "H4",
      "H10",
      "H3",
      "H6",
      "H8",
      "H7",
      "H12",
      "H9",
      "H11"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aflibercept",
          "type": "Drug",
          "label": "Aflibercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_copanlisib",
          "type": "Drug",
          "label": "Copanlisib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_belimumab",
          "type": "Drug",
          "label": "Belimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sunitinib",
          "type": "Drug",
          "label": "Sunitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_a_hus",
          "type": "Disease",
          "label": "Atypical haemolytic uraemic syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_cd5",
          "type": "Target",
          "label": "CD5",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_inhibition",
          "type": "Pathway",
          "label": "Inhibition Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_eculizumab",
          "type": "Target",
          "label": "OffTarget_Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_eculizumab",
          "type": "Pathway",
          "label": "RiskPathway_Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_eculizumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ravulizumab",
          "type": "Target",
          "label": "OffTarget_Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ravulizumab",
          "type": "Pathway",
          "label": "RiskPathway_Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ravulizumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_aflibercept",
          "type": "Target",
          "label": "OffTarget_Aflibercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_aflibercept",
          "type": "Pathway",
          "label": "RiskPathway_Aflibercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_aflibercept",
          "type": "Phenotype",
          "label": "AdversePhenotype_Aflibercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Eculizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Aflibercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Copanlisib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Belimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Sunitinib",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_eculizumab",
          "target": "target_cd5",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Eculizumab对CD5的已知作用"
        },
        {
          "source": "drug_ravulizumab",
          "target": "target_cd5",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Ravulizumab对CD5的已知作用"
        },
        {
          "source": "drug_aflibercept",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "有文献支持其通过通路抑制影响疾病"
        },
        {
          "source": "drug_corticosteroids",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "普遍接受的药理作用"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "d_a_hus",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过血液净化机制支持疾病改善"
        },
        {
          "source": "drug_methotrexate",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "推测作用于相关免疫通路"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "target_cd5",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "有研究表明其对CD5的抑制作用"
        },
        {
          "source": "drug_tacrolimus",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "推测作用于抑制免疫途径"
        },
        {
          "source": "drug_copanlisib",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "潜在影响相关的细胞通路"
        },
        {
          "source": "drug_rituximab",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "文献中表明对相关免疫途径的影响"
        },
        {
          "source": "drug_belimumab",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "可能有助于症状改善"
        },
        {
          "source": "drug_sunitinib",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "推测可影响血管生成相关通路"
        },
        {
          "source": "d_a_hus",
          "target": "H1",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "药物对疾病的已知效用"
        },
        {
          "source": "d_a_hus",
          "target": "H2",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "药物对疾病的已知效用"
        },
        {
          "source": "drug_eculizumab",
          "target": "n_ot_eculizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "n_ot_eculizumab",
          "target": "n_rp_eculizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_eculizumab",
          "target": "n_adv_eculizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_eculizumab",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立将抵消净获益"
        },
        {
          "source": "drug_ravulizumab",
          "target": "n_ot_ravulizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "n_ot_ravulizumab",
          "target": "n_rp_ravulizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_ravulizumab",
          "target": "n_adv_ravulizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_ravulizumab",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立将抵消净获益"
        },
        {
          "source": "drug_aflibercept",
          "target": "n_ot_aflibercept",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "n_ot_aflibercept",
          "target": "n_rp_aflibercept",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_aflibercept",
          "target": "n_adv_aflibercept",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_aflibercept",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立将抵消净获益"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "已知作用机制支持对 atypical HUS 的改善"
        ],
        "caveats": [
          "存在安全性与长期疗效的担忧"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "作用机制与 Eculizumab 相似，支持对 atypical HUS 的疗效"
        ],
        "caveats": [
          "安全性与长期疗效的问题仍待验证"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "score": 0.7,
        "graph_snapshot_ref": "GE_H5_round4",
        "key_assumptions": [
          "通过血液净化改善病情的机制得到支持"
        ],
        "caveats": [],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "score": 0.65,
        "graph_snapshot_ref": "GE_H4_round4",
        "key_assumptions": [
          "普遍接受的免疫调节治疗方法"
        ],
        "caveats": [
          "长期疗效的缺乏证据"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H10",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "score": 0.58,
        "graph_snapshot_ref": "GE_H10_round4",
        "key_assumptions": [
          "文献中有对其治疗作用的理论支持"
        ],
        "caveats": [
          "缺乏足够的数据验证其疗效"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Eculizumab, Ravulizumab → CD5 作用",
          "reason": "已知机制支持对 atypical HUS 的效用"
        }
      ],
      "remaining_gaps": [
        "安全性问题在图中尚未充分解决，需进一步评估风险通路"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "确认治疗偏好的机理及其效果，尤其在长期疗效和安全性方面。"
      },
      {
        "role": "Skeptic",
        "patch": "对潜在的不良表型标明具体的风险，并提供可证伪的评估数据。"
      },
      {
        "role": "Explorer",
        "patch": "增加不同治疗机制的候选药物，以增加多样性并高效解决安全性问题。"
      }
    ],
    "heuristics": [
      {
        "when": "atypical HUS 治疗",
        "then": "明确表征疗效与安全性的两阶段分析"
      }
    ]
  }
}